Kristin Burke is a Gastroenterology physician affiliated with Harvard University. OpenAlex indexes 86 publications with 5,597 citations (h-index 25).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
55 Fruit St
Boston, MA 021142621
Telephone
617-726-2426Registry record last updated 25 Apr 2019.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Biotech, Inc.Program year20252 payments
- Zimmer Biomet Holdings, Inc.Program year20251 payment
- Janssen Biotech, Inc.Program year20248 payments$11,227openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
45%TNF inhibitor15.3%Humira(Cf) Pen75%Cimzia (2 Pack)25%Part D<11 patientsInterleukin-12 Antagonist15.3%Stelara100%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
44.1%Proton pump inhibitor18.2%Omeprazole75%Pantoprazole Sodium25%Part D<11 patientsAminosalicylate13.7%Mesalamine100%Part D≥11 patients+ 1 more class in this area
Respiratory
7.3%Corticosteroid7.3%Budesonide Ec100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2018–2026 per NIH RePORTER. The latest:
- Diet and metabolic factors in the pathogenesis of microscopic colitis
Massachusetts General Hospital
FY2026$196,248K23DK131366 - Diet and metabolic factors in the pathogenesis of microscopic colitis
Massachusetts General Hospital
FY2025$196,248K23DK131366 - Diet and metabolic factors in the pathogenesis of microscopic colitis
Massachusetts General Hospital
FY2024$196,248K23DK131366
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Association of distinct microbial and metabolic signatures with microscopic colitis
Nature Communications
2025 - Discovery of disease-adapted bacterial lineages in inflammatory bowel diseases
Cell Host & Microbe
2024 - Association of Childhood Abuse With Incident Inflammatory Bowel Disease
Clinical and Translational Gastroenterology
2024 - Comparative Effectiveness of Upadacitinib and Tofacitinib in Inducing Remission in Ulcerative Colitis: Real-World Data
Clinical Gastroenterology and Hepatology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Felipe Fregni, MD, MPH
Harvard University
Joseph Antin, MD
Harvard University
Sarah Fortune, MD
Harvard University
Elizabeth Buchbinder, MD
Harvard University
Charles Rice, MD
The Rockefeller University
Edward Loftus, MD
Mayo Clinic Rochester
Naga Chalasani, MD
Indiana University School of Medicine
Bruce Sands, MD
Icahn School of Medicine at Mount Sinai
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”